[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 792885, "exercisedValue": 0, "unexercisedValue": 357187}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 603956, "exercisedValue": 0, "unexercisedValue": 496087}, {"maxAge": 1, "name": "Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695243, "exercisedValue": 0, "unexercisedValue": 434807}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 50, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Conor  Richardson CPA", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "age": 48, "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 52, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Co-Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Co-Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1730419200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.09, "open": 1.1, "dayLow": 1.06, "dayHigh": 1.11, "regularMarketPreviousClose": 1.09, "regularMarketOpen": 1.1, "regularMarketDayLow": 1.06, "regularMarketDayHigh": 1.11, "beta": 1.863, "forwardPE": -1.1786443, "volume": 113518, "regularMarketVolume": 113518, "averageVolume": 289452, "averageVolume10days": 112590, "averageDailyVolume10Day": 112590, "bid": 1.06, "ask": 1.15, "bidSize": 100, "askSize": 100, "marketCap": 52991068, "fiftyTwoWeekLow": 0.94, "fiftyTwoWeekHigh": 11.76, "priceToSalesTrailing12Months": 12.849435, "fiftyDayAverage": 1.1735, "twoHundredDayAverage": 4.12815, "currency": "USD", "enterpriseValue": -36138640, "floatShares": 27692793, "sharesOutstanding": 47739700, "sharesShort": 2192022, "sharesShortPriorMonth": 5451660, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.045900002, "heldPercentInsiders": 0.13414, "heldPercentInstitutions": 0.74675006, "shortRatio": 1.76, "shortPercentOfFloat": 0.069, "impliedSharesOutstanding": 47739700, "bookValue": 3.062, "priceToBook": 0.36250818, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -85284000, "trailingEps": -1.53, "forwardEps": -1.07, "enterpriseToRevenue": -8.763, "enterpriseToEbitda": 0.419, "52WeekChange": -0.88742393, "SandP52WeekChange": 0.23631513, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "messageBoardId": "finmb_378179277", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.11, "targetHighPrice": 1.2, "targetLowPrice": 1.2, "targetMeanPrice": 1.2, "targetMedianPrice": 1.2, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 105344000, "totalCashPerShare": 2.207, "ebitda": -86318000, "totalDebt": 3819000, "quickRatio": 7.011, "currentRatio": 7.615, "totalRevenue": 4124000, "debtToEquity": 3.452, "revenuePerShare": 0.088, "returnOnAssets": -0.39741, "returnOnEquity": -0.68481004, "grossProfits": -70517000, "freeCashflow": -31852376, "operatingCashflow": -63230000, "revenueGrowth": 7.045, "operatingMargins": -14.27098, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-18"}]